HHS Decertifies Kentucky Organ Procurement Organization After 'Persistent Patient Safety Failures'

Decertification Follows Findings of 'Unconscionable' Practices

The U.S. Department of Health and Human Services (HHS) has begun decertifying Network for Hope, the federally designated organ procurement organization (OPO) serving Kentucky and portions of Indiana, Ohio, and West Virginia. The action, announced August 7, 2026, follows multiple federal reviews by the Centers for Medicare & Medicaid Services (CMS) and the Health Resources and Services Administration (HRSA) that uncovered persistent patient safety failures despite repeated opportunities for correction.

The most severe allegations include pushing forward with organ recovery procedures even when patients exhibited signs of life, conducting inadequate neurological assessments to confirm death, and securing questionable consent from families. Lawmakers on the House Energy and Commerce Committee and the Ways and Means Committee, which conducted parallel oversight hearings, described the organization’s conduct as "unconscionable" and "a grave threat to the health and well-being of American patients."

HHS Secretary Robert F. Kennedy Jr. framed the decertification as a restoration of trust: "Americans who choose to become organ donors deserve a system that honors their gift and protects every patient. Organizations that repeatedly fail to meet federal standards and put patients at risk will be held accountable." The move is only the second such decertification in recent memory and directly impacts roughly 7 million people across the four-state donor service area, as well as hundreds of patients awaiting lifesaving transplants.

Why the Network for Hope Case Matters for the Entire Transplant Industry

A New Enforcement Era for Organ Procurement

The decertification signals a marked shift in federal oversight. After the 2023 legislative reforms that gave HHS clearer authority to terminate underperforming OPOs, this administration is using that power aggressively. The action against Network for Hope follows a similar decertification elsewhere and comes amid intense congressional scrutiny led by Representatives Brett Guthrie, Jason Smith, and David Schweikert. Their investigations unearthed not only patient-safety lapses but also what Smith called "fraud and medical misconduct." The decertification is thus both a regulatory and a political statement, reinforcing the Trump administration’s health-agency posture that patient safety and accountability will not be compromised.

Trust in the Transplant System at a Critical Juncture

Public confidence in organ donation relies on the absolute certainty that death is declared before organs are taken. Allegations that Network for Hope proceeded with organ recovery in cases where patients showed signs of life—including the widely reported case of TJ Hoover, whose sister said he wept as he was wheeled into the operating room—directly undermine that trust. Experts like Jennifer Erickson of the Federation of American Scientists warned that the organization posed an "ongoing, deadly risk" to millions. The decertification is, as Organize CEO Greg Segal put it, "the only way to restore public trust." But the damage may already be deep: if families come to fear that hospitals or OPOs have financial incentives to hasten death declarations, donation rates could fall, worsening the already dire organ shortage.

Industry Reactions: Support Mixed with Caution

The Association of Organ Procurement Organizations (AOPO) said it "fully supports actions to strengthen our nation’s organ donation and transplant system" and backs decertification when standards are not met. Yet the strong language from other observers—including comparisons to "Exhibit B" for why people distrust doctors—reveals a broader reputational crisis for the entire OPO sector. Network for Hope itself had not yet commented on whether it would fight the decertification. If it does, as some analysts expect, a prolonged legal battle could delay the transition and leave the donor service area in limbo, putting transplant programs and waiting patients at added risk.

What Comes Next: Selecting a New OPO and a System in Flux

HHS will now shepherd the selection of a new OPO to take over the donor service area. The process is complex and could take months. In the interim, hospitals in the region will need to coordinate directly with HHS and alternative procurement networks, which may strain already stretched transplant centers. The episode also gives momentum to voices calling for more fundamental reform—such as former Kentucky OPO employee Nycki Martin’s suggestion that power should be "taken back to the hospital and to the donors and their families," reducing the role of OPOs. While decertification addresses a single bad actor, it has exposed structural vulnerabilities that Congress and regulators will almost certainly revisit in the coming months.

What Hospitals, Other OPOs and Policymakers Must Do Now

For Other Organ Procurement Organizations:

• Immediately audit neurological-death determination protocols, consent procedures, and internal whistleblower mechanisms. The Network for Hope case demonstrates that CMS and HRSA are now willing to use decertification for systemic failures, not just isolated errors.
• Review the 2023 Organ Procurement and Transplant System reforms and upcoming CMS survey criteria; compliance with the new standards will determine survival.
• Expect heightened congressional interest. The Ways and Means and Energy and Commerce committees have subpoena power and have signaled they will continue investigating OPO practices. Transparent records and a demonstrable commitment to patient safety are the best defense against being the next case.

For Hospitals and Transplant Centers in Kentucky, Ohio, Indiana and West Virginia:

• Identify the interim organ-recovery arrangements announced by HHS for the service area. Transplant programs must immediately communicate any changes in referral protocols to clinical staff to avoid delays.
• Prepare for a potentially protracted transition to a new OPO. Engage with the Health Resources and Services Administration to understand the timeline and contingency plans, especially for high-urgency organ offers.
• Review internal policies on declaring death to ensure they are entirely independent of OPO influence—a principle the Hoover case puts under a harsh spotlight.

For Policymakers and Regulators:

• The decertification validates the 2023 reforms but also reveals that oversight gaps persisted for years. Consider mandating real-time audit trails for OPO activities and strengthening the firewall between OPOs and the transplant centers they serve.
• Monitor public donor registration trends in the affected states. If the Hoover case leads to a sustained drop in consent rates, the organ shortage could deepen, requiring a rapid public-information campaign emphasizing that the decertification was precisely about protecting donors.
• Evaluate the criminal referral potential explicitly raised by lawmakers and the sister of TJ Hoover. Even without successful prosecution, the signal of federal intent would further deter OPO misconduct.